Clinical Trial Update: SMILES: Study of Montelukast in Sickle Cell Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for Montelukast in sickle cell disease progressing through Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Great Ormond Street Hospital for Children NHS Foundation Trust | Conditions: Anemia, Sickle Cell, Sleep-Disordered Breathing | Phase 2, Phase 3 | Status: UNKNOWN